Vulinacimab (Anti-VEGFR2 / KDR / CD309)Vulinacimab (Anti-VEGFR2 / KDR / CD309)
Move your mouse over image or click to enlarge

Vulinacimab (Anti-VEGFR2 / KDR / CD309)

Vulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD.
Cat# Size Price Qty Buy
A3110-1mg*25 1mg*25
£4,152.00
A3110-1mg*5 1mg*5
£1,384.00
A3110-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3110

Related Documents